Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia

Atorvastatin, a synthetic HMG-CoA reductase inhibitor used for the treatment of hyperlipidemia and the prevention of coronary artery disease, significantly lowers plasma cholesterol and low-density lipoprotein cholesterol (LDL-C) levels. It also reduces total plasma triglyceride and apoE concentrati...

Full description

Bibliographic Details
Main Authors: Jeffrey S. Cohn, Michel Tremblay, Rami Batal, Hélène Jacques, Lyne Veilleux, Claudia Rodriguez, P.Hugh R. Barrett, Denise Dubreuil, Madeleine Roy, Lise Bernier, Orval Mamer, Jean Davignon
Format: Article
Language:English
Published: Elsevier 2002-09-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520328108